CCL4L2 and Alzheimer disease: Because of their potential implication in inflammatory processes and AD, we also evaluated the abundance of four supplemental proteins present in our panels: GRO-gamma, RANTES, MIP-1beta, and FABP3, which were also described in the literature as putative AD biomarkers.